健康状况
14 基于循证研究的健康状况与补充剂信息
We evaluate supplements across specific sleep-related conditions. Each condition page ranks ingredients by evidence grade, showing you what the research says about supplements for insomnia, restless sleep, and more.
How We Grade Evidence
每个健康状况页面按临床证据强度对补充剂成分进行排序。以下是各等级的含义:
Strong Evidence
Multiple randomized controlled trials (RCTs) or meta-analyses with consistent positive results and large sample sizes.
Good Evidence
At least one RCT with mostly consistent results across studies. Evidence suggests benefit but more research may be needed.
Some Evidence
Small studies or observational data with some positive signals. Promising but insufficient for strong recommendations.
Very Early Research
In vitro studies, case reports, or pilot studies only. Early-stage research that requires clinical validation.
不宁腿综合征
5-10% of adults; 2-3% have clinically significant symptoms
入睡困难
15-20% of adults report difficulty falling asleep
失眠
10-15% chronic insomnia; 30-35% occasional symptoms
年龄相关性睡眠变化
Affects majority of adults over 60
时差综合征
Affects most transmeridian travelers (>3 time zones)
昼夜节律障碍
0.13-0.17% delayed sleep phase; higher in adolescents
焦虑相关性睡眠问题
70-80% of anxiety disorder patients report sleep problems
睡眠呼吸暂停
9-38% of general population; higher with obesity
睡眠维持性失眠
More common in older adults; affects ~15% of population
轮班工作睡眠障碍
10-38% of shift workers
Hyperarousal and Cognitive Insomnia
Central feature in 50-70% of chronic insomnia cases
Menopause-Related Sleep Disturbance
40-60% of perimenopausal and postmenopausal women
Nighttime Pain-Related Sleep Disruption
50-80% of chronic pain patients report sleep disruption
Pregnancy-Related Sleep Disruption
75-90% of pregnant women report sleep problems, especially in third trimester
FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。